FA
FLGT icon

Financial Advisors’s Fulgent Genetics FLGT Stock Holding History

Financial Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,000
Closed -$601K – 81
2020
Q3 		$601K Sell
15,000
-4,000
-21% -$125K 0.32% 24
2020
Q2 		$304K Hold
19,000
– – 0.17% 49
2020
Q1 		$204K Buy
+19,000
New +$265K 0.14% 59
2019
Q1 		– Sell
-10,900
Closed -$35K – 61
2018
Q4 		$35K Buy
+10,900
New +$38.3K 0.03% 58

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Financial Advisors's FLGT Position: Q4 2020 in Review

Financial Advisors sold out of Fulgent Genetics (FLGT) in Q4 2020, closing a stake of 15,000 shares — an estimated $601K sold.

Financial Advisors first reported a position in FLGT in Q4 2018 and held it in 4 quarters. The position peaked at $601K in Q3 2020. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2020.

  • Financial Advisors reported no remaining Fulgent Genetics position as of Q4 2020 after selling out during the quarter.
  • Financial Advisors sold 15,000 Fulgent Genetics shares in Q4 2020, an estimated $601K.
  • Financial Advisors first reported a position in Fulgent Genetics in Q4 2018 and held it in 4 quarters.
  • Financial Advisors's Fulgent Genetics position peaked at $601K in Q3 2020.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2020.

Based on Financial Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.